An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Launched by ANN & ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO · Dec 24, 2020

Keywords

ClinConnect Summary

This clinical trial is studying a mobile health app called MED-Go, designed to help adolescents and young adults with sickle cell disease remember to take their medication. The main goal is to see if using this app can encourage better medication habits, which may lead to improved health for these young patients. Researchers are currently looking for participants aged 12 to 21 who have been stable on a medication called hydroxyurea for at least two months and have access to a smartphone.

If you or someone you know is eligible and decides to participate, you will be part of a study that tests how well the MED-Go app works. Participants will receive the app and will be asked to use it over a period of time. This is a great opportunity to help improve care for young people with sickle cell disease while also contributing to research that could benefit many others in the future. Please note that individuals who have been hospitalized in the past week cannot take part in this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 12-21 years old
• • Any sickle cell disease genotype
• • On steady state of hydroxyurea for 2 months
• • Own of have access to a smartphone during the study period
• Exclusion Criteria:
• • Recent hospitalizations within the past 7 days